Federal vs. State Malpractice Law: Jurisdictional Framework

The division of authority between federal and state governments shapes nearly every procedural and substantive rule that applies to a malpractice claim in the United States. This page maps the jurisdictional framework governing medical, legal, and professional malpractice — identifying which court systems, statutes, and regulatory bodies control which aspects of a claim, and where those authorities overlap or conflict. Understanding this framework is essential for interpreting why caps on malpractice damages, statutes of limitations, and procedural prerequisites differ so dramatically across the country.



Definition and scope

Malpractice law in the United States is predominantly state tort law. Each state legislature and judiciary defines the standard of care in malpractice law, acceptable damages frameworks, and procedural prerequisites for filing suit. The federal government does not operate a unified national malpractice statute for privately retained professionals. Instead, federal involvement is channeled through specific statutes, constitutional provisions, and administrative programs that intersect with — but do not displace — state-level tort systems.

"Jurisdiction" in this context carries two distinct meanings: subject-matter jurisdiction (which court system has authority to hear the case) and substantive jurisdiction (which body of law governs the merits). A malpractice claim may be filed in state court under state substantive law, in federal court under diversity jurisdiction while still applying state substantive law, or under a federal statute that creates its own cause of action — each path producing different procedural rules and, potentially, different outcomes.

The scope of federal authority is largely defined by the Supremacy Clause (U.S. Const. art. VI, cl. 2), the Tenth Amendment's reservation of police powers to the states, and the Erie doctrine established in Erie Railroad Co. v. Tompkins, 304 U.S. 64 (1938), which requires federal courts sitting in diversity to apply the substantive law of the state in which they sit.


Core mechanics or structure

State tort systems as the baseline

All 50 states maintain independent common-law and statutory tort frameworks. These frameworks govern the core elements of a malpractice claim — duty, breach, causation, and damages — as well as procedural requirements such as pre-suit notice, mandatory mediation panels, and certificate-of-merit filings. Because these rules originate in state law, they vary substantially: at least 33 states impose statutory caps on noneconomic or total damages (American Tort Reform Association, Tort Reform Record, 2023), while others have had such caps struck down by state supreme courts on state constitutional grounds.

Federal court as an alternative venue

Federal district courts acquire jurisdiction over malpractice claims primarily through 28 U.S.C. § 1332, the diversity jurisdiction statute, when the parties are citizens of different states and the amount in controversy exceeds $75,000. Under the Erie doctrine, the federal court applies the substantive tort law of the forum state — including any damages caps and statutes of limitations — while applying the Federal Rules of Civil Procedure (Fed. R. Civ. P.) for procedural matters.

Federal statutes creating independent causes of action

Several federal statutes operate in the malpractice space without relying on state law:


Causal relationships or drivers

The dominance of state law over malpractice claims is not accidental — it flows from structural constitutional design. The Tenth Amendment reserves to states the "police power" to regulate health, safety, and welfare. State licensing boards, established under that police power, set professional standards that in turn define the duty element of a tort claim. Because licensing is state-controlled, the standard against which conduct is measured is inherently state-specific.

Congressional reluctance to federalize malpractice law is also driven by political economy. Proposed legislation such as the Health Act (H.R. 5 in the 117th Congress) would have imposed national caps of $250,000 on noneconomic damages, but it did not advance through the Senate. The American Medical Association (AMA) and trial lawyer organizations have historically opposed each other's preferred reforms, producing legislative stalemate at the federal level.

The FTCA framework demonstrates how federal involvement does reach malpractice when the federal government itself is the employer. In those cases, the administrative exhaustion requirement — filing an administrative claim with the relevant agency before suit — adds a mandatory prerequisite absent from most state systems.


Classification boundaries

The jurisdictional framework can be divided into four operative categories:

  1. Purely state-law claims: Private professional against private patient or client, both domiciled in the same state, amount in controversy below $75,000. Resolved entirely under state substantive and procedural law in state court.

  2. State-law claims in federal court (diversity): Same substantive state law applies; federal procedural rules govern. Forum selection, discovery scope, and jury instructions may differ from state court practice.

  3. Federal statutory claims: Claims arising under the FTCA, VICP, or other federal programs. Federal substantive rules govern liability structure, though FTCA claims borrow state negligence standards for the merits.

  4. Mixed federal-state claims: A plaintiff may assert both a federal civil rights claim (e.g., 42 U.S.C. § 1983 for constitutional violations by state actors) and a state malpractice claim in the same action. Federal courts may exercise supplemental jurisdiction over the state claim under 28 U.S.C. § 1367.

These boundaries determine which statute of limitations for malpractice claims applies, which discovery rules govern, whether a certificate of merit is required, and whether punitive damages are available.


Tradeoffs and tensions

Erie friction

Erie created a structural tension that remains unresolved in edge cases. Federal courts must apply state substantive law but federal procedural law — yet the line between "substance" and "procedure" is contested. In Gasperini v. Center for Humanities, Inc., 518 U.S. 415 (1996), the Supreme Court held that New York's standard for reviewing jury damage awards was sufficiently intertwined with substantive state policy to require its application in federal court. This means the same malpractice claim can produce different damages outcomes depending solely on whether it lands in state or federal court, even when applying the same state's nominal substantive rules.

Federal preemption uncertainty

Medical device manufacturers have successfully argued that state malpractice claims based on design defects are preempted by the Medical Device Amendments to the Federal Food, Drug, and Cosmetic Act — as confirmed in Riegel v. Medtronic, Inc., 552 U.S. 312 (2008). Pharmaceutical tort claims, by contrast, are generally not preempted because FDA approval does not preclude state failure-to-warn claims (Wyeth v. Levine, 555 U.S. 555 (2009)). This asymmetry creates classification challenges when malpractice involves a device versus a drug.

FTCA administrative exhaustion

The mandatory administrative exhaustion requirement under 28 U.S.C. § 2675 — claimants must first file with the responsible federal agency and wait up to 6 months for a response before suing — introduces delays absent from state court practice, directly affecting how malpractice pre-suit requirements function in federal employee cases.


Common misconceptions

Misconception 1: Federal law sets a national standard of care.
No federal statute establishes a uniform clinical standard of care for malpractice purposes. The standard is always derived from state law, expert testimony, and relevant professional guidelines. Federal agencies such as the Centers for Medicare & Medicaid Services (CMS) set participation conditions (42 C.F.R. Part 482), but violation of those conditions does not, by itself, establish negligence per se in every state.

Misconception 2: Winning a malpractice suit in one state binds other states.
State court judgments receive full faith and credit under U.S. Const. art. IV, § 1 as to the judgment itself, but the underlying legal standards and damages rules of one state do not migrate with the judgment to another state's practitioners.

Misconception 3: Federal court is always advantageous for plaintiffs.
Forum selection involves genuine tradeoffs. Federal courts apply stricter pleading standards under Bell Atlantic Corp. v. Twombly, 550 U.S. 544 (2007), and Ashcroft v. Iqbal, 556 U.S. 662 (2009), which may result in dismissal of claims that would survive under more permissive state pleading rules.

Misconception 4: FTCA claims follow standard malpractice procedure.
FTCA claims require administrative exhaustion before filing, carry a 2-year statute of limitations running from the date of accrual (28 U.S.C. § 2401(b)), and do not permit jury trials — a federal judge, not a jury, decides liability and damages. These differences are fundamental departures from typical state malpractice procedure.

Misconception 5: The National Practitioner Data Bank (NPDB) is a federal enforcement mechanism.
The NPDB is a federal reporting and query system established under 45 C.F.R. Part 60 and administered by the Health Resources and Services Administration (HRSA). It records malpractice payment reports and adverse licensing actions, but it does not adjudicate claims, set standards, or impose discipline — those functions remain with state licensing boards.


Checklist or steps (non-advisory)

The following sequence outlines the jurisdictional determination points applicable to any U.S. malpractice claim. This is a structural reference, not legal guidance.

Step 1 — Identify the defendant's employment status.
Determine whether the defendant is a federal employee, a FQHC-deemed provider, a private practitioner, or a state/local government employee. This determines whether the FTCA, state sovereign immunity rules, or private tort law governs.

Step 2 — Identify the applicable state.
Determine the state where the act or omission occurred. This state's substantive law will govern whether the claim proceeds under state court, federal diversity, or FTCA framework.

Step 3 — Check federal program pre-emption.
Determine whether the claim involves a federally approved medical device (potential Riegel preemption), a vaccine (potential VICP channeling), or an FDA-regulated pharmaceutical (analyze Wyeth failure-to-warn exception).

Step 4 — Evaluate diversity jurisdiction.
If parties are from different states, calculate the amount in controversy against the $75,000 threshold under 28 U.S.C. § 1332. If met, federal court is an optional venue, but state substantive law still applies.

Step 5 — Identify state-specific procedural prerequisites.
Under applicable state law, determine whether a certificate of merit, medical review panel, or pre-suit notice is required before filing.

Step 6 — Confirm the statute of limitations and repose.
Cross-reference the state's limitations period and any statute of repose, plus the FTCA's 2-year limit if a federal employee is involved.

Step 7 — Assess damages rules.
Identify whether the applicable state imposes caps on noneconomic or total malpractice damages, and whether those caps have survived state constitutional review.

Step 8 — Determine reporting obligations.
Confirm whether any settlement or judgment triggers a mandatory NPDB report under 45 C.F.R. § 60.7 and whether the state licensing board requires parallel notification.


Reference table or matrix

Dimension State Court / State Law Federal Court (Diversity) FTCA (Federal Employee) Federal Statutory Program (VICP, etc.)
Governing substantive law State tort law State tort law (Erie) State negligence law as borrowed by 28 U.S.C. § 2674 Federal statute (e.g., 42 U.S.C. § 300aa)
Procedural rules State rules of civil procedure Federal Rules of Civil Procedure Federal Rules of Civil Procedure Program-specific administrative rules
Jury trial available? Yes (varies by state) Yes (7th Amendment) No — bench trial only No — administrative adjudication
Pre-suit requirement State-specific (certificate of merit, panel) State pre-suit rules may still apply Mandatory administrative claim (28 U.S.C. § 2675) Program filing before tort suit
Statute of limitations State-specific (typically 2–3 years) State limitations applies 2 years from accrual (28 U.S.C. § 2401(b)) Program-specific (VICP: 3 years from symptoms)
Damages caps State statutory caps (33+ states) State caps apply Capped by state law; no punitive damages Program-specific award schedules
Punitive damages State law controls State law controls Prohibited under FTCA Generally prohibited
Licensing/discipline State licensing board (state police power) State board still controls State board + federal agency oversight State board controls separately
NPDB reporting Required on payment Required on payment Required on payment Required on compensation awards
Preemption risk Not applicable Device preemption possible (Riegel) Not applicable Vaccine claims channeled away from state court

References

📜 16 regulatory citations referenced  ·  ✅ Citations verified Mar 02, 2026  ·  View update log

Explore This Site